How Hartford HealthCare Research is Paving the Future of Health

Before big announcements come the work, and Hartford HealthCare cultivates rich clinical research to ultimately improve patient experience, health outcomes and safety.

Led by Rocco Orlando, MD, senior vice president and chief academic officer, and Lizabeth Roper, senior director of research, the projects uncover advances in diagnosis and treatment options, and pave the way for the future.

Hartford HealthCare’s top research areas are:

• Behavioral health – The Institute of Living has three research centers – Olin Neuropsychiatry Research Center headed by Godfrey Pearlson, MD, and Michael Stevens, PhD; Anxiety Disorders Center led by David Tolin, MD; and Clinical Trials Unit under Mirjana Domakonda, MD. Recently, Olin researchers received a $3.2-million National Institute of Mental Health (NIMH) grant to investigate the effects of social isolation in older patients with schizophrenia; and a $1.4-million NIMH grant to study the path of people with early course psychotic disorders treated in specialty programs. The latter researchers will also identify clinical and biological features, and biological subtypes of psychotic disorders to help predict outcomes and tailor effective treatment.

For more, continue here.